The results of computed tomography guided tru-cut transthoracic biopsy: complications and related risk factors

Basit Öğe Kaydı
dc.contributor.authorBesir, Fahri Halit
dc.contributor.authorAltin, Remzi
dc.contributor.authorKart, Levent
dc.contributor.authorAkkoyunlu, Muhammed
dc.contributor.authorOzdemir, Huseyin
dc.contributor.authorOrnek, Tacettin
dc.contributor.authorGundogdu, Sadi
dc.date.accessioned2024-06-12T11:13:08Z
dc.date.available2024-06-12T11:13:08Z
dc.date.issued2011
dc.departmentTrakya Üniversitesien_US
dc.description.abstractIntroduction: Transthoracic biopsy (TTB) is a well-defined and effective method used for pathologic sampling in the diagnosis of the pulmonary lesions. It is less invasive in comparison to surgical procedures. In addition, diagnostic rate of tru-cut biopsy is higher than that of fine needle aspiration biopsy (FNAB) especially for benign lesions. In this study, we presented tru-cut transthoracic biopsy (TTB) procedure results and the frequency of TTB complications with related risk factors. Material and methods:A total of 102 patients were evaluated by CT scan guided tru-cut TTB in the diagnosis of lung lesions between January 2003 and December 2007. The complications due to tru-cut TTB were recorded. The factors such as the lesion depth, the lesion size, and the emphysematous changes that accompany the lesion were evaluated through chi(2) test. Results: Among the samples, 51% malignancy and 49% benign pathology were observed. Pneumothorax developed in 15.7% of the 102 procedures. It was found that the lesion's distance from the pleura, the size of the lesion, and emphysematous changes around the lesion significantly increased the risk of pneumothorax. Discussion: The tru-cut biopsy complications are similar to those of FNAB. In the centers where cytologic examination is insufficient in the diagnosis of lung lesions, tru-cut biopsy should be routinely performed as it is a reliable biopsy technique compared to FNAB.en_US
dc.identifier.doi10.1007/s00508-011-1538-y
dc.identifier.endpage82en_US
dc.identifier.issn0043-5325
dc.identifier.issn1613-7671
dc.identifier.issue3-4en_US
dc.identifier.pmid21327675en_US
dc.identifier.scopus2-s2.0-79952279847en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage79en_US
dc.identifier.urihttps://doi.org/10.1007/s00508-011-1538-y
dc.identifier.urihttps://hdl.handle.net/20.500.14551/23439
dc.identifier.volume123en_US
dc.identifier.wosWOS:000289216800003en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringer Wienen_US
dc.relation.ispartofWiener Klinische Wochenschriften_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectPulmonary Lesionen_US
dc.subjectTransthoracic Biopsyen_US
dc.subjectTru-Cuten_US
dc.subjectPneumothoraxen_US
dc.subjectHemoptysisen_US
dc.subjectNeedle Aspiration Biopsyen_US
dc.subjectPulmonary-Lesionsen_US
dc.subjectThoracic Lesionsen_US
dc.subjectLung Lesionsen_US
dc.subjectPneumothoraxen_US
dc.subjectSpirometryen_US
dc.subjectVariablesen_US
dc.titleThe results of computed tomography guided tru-cut transthoracic biopsy: complications and related risk factorsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu